Trials / Unknown
UnknownNCT06204419
A Phase I Study of XH-S002 in Healthy Volunteers
A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of XH-S002 After Single Ascending Doses, Multiple Ascending Doses and Evaluation of Food Effects in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 86 (estimated)
- Sponsor
- S-INFINITY Pharmaceuticals Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of XH-S002 in healthy volunteers under SAD (Single ascending dose) and MAD (Multiple ascending dose) studies. In addition, this study evaluates the food effects of XH-S002.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | XH-S002 （A） | XH-S002 powder will be administered orally as per assigned treatment regimen. |
| OTHER | Placebo（B） | XH-S002 Placebo (matched) will be administered orally as per assigned treatment regimen. |
Timeline
- Start date
- 2023-12-26
- Primary completion
- 2024-07-01
- Completion
- 2024-10-01
- First posted
- 2024-01-12
- Last updated
- 2024-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06204419. Inclusion in this directory is not an endorsement.